Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Invest Dermatol. 2019 Jun 26;140(1):143–151.e3. doi: 10.1016/j.jid.2019.06.127

Figure 4. IL-19 limits accumulation of IL-17+ dermal γδT cells.

Figure 4.

(a, b) Representative flow cytometric analyses for markers shown of cells obtained from IMQ-treated ears (a) and earsDLNs (b) of CIKS ΔKC mice i.d. injected with PBS or IL-19. Numbers and percentages of IL-17A+ γδT cells generated from flow cytometric analyses. (**p < 0.01; mean ± SEM; n = 6–8 mice per group). (c, d) Representative flow cytometric analyses for markers shown of cells obtained from IMQ-treated dorsal skin (c) and sDLNs (d) of WT mice injected i.p. with PBS or FTY720. Numbers and percentages of IL-17A+ γδT cells generated from flow cytometric analyses. (**p < 0.01; mean ± SEM; n = 6–9 mice per group).